Advocacy intelligence hub — real-time data for patient organizations
Stella Pharma Corporation — PHASE1, PHASE2
Day One Biopharmaceuticals, Inc. — PHASE3
University of Florida — PHASE2
Children's Oncology Group — PHASE2
Ascentage Pharma Group Inc. — PHASE1, PHASE2
Bayer — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Brigitte C Widemann, M.D.
National Cancer Institute (NCI)
📍 Bethesda, Maryland
Brigitte C. Widemann, MD, M.D
National Cancer Institute (NCI)
📍 BETHESDA, MD
Yen-Lin Chen, MD, MD
Massachusetts General Hospital
📍 BOSTON, MA
Margaret von Mehren
Fox Chase Cancer Center
Joanne Lagmay, MD, MD
University of Florida
📍 GAINESVILLE, FL
Robert Maki, MD, PhD, MD, PhD
Memorial Sloan Kettering Cancer Center
📍 PHILADELPHIA, PA